Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Oral Care in connection with the acquisition of Dutch dental care provider De Tandartsengroep (DTG)
Mandate

Vinge advises Oral Care in connection with the acquisition of Dutch dental care provider De Tandartsengroep (DTG)

February 19, 2025 Banking and Finance Employment and Benefits M&A Intellectual Property Commercial Agreements

DTG operates 31 clinics and 8 dental laboratories in the Netherlands. Oral Care is a portfolio company of Axcel VI and operates a network of dental clinics in Sweden, Norway and the Netherlands. To support this expansion, Axcel VII is joining Axcel VI as a shareholder in Oral Care.

The transaction is subject to customary approval by the Dutch Health Care Authority and the Dutch Authority for Consumers and Markets (ACM).

Vinge's team consisted of Christina Kokko, Manon de Cooman, Gustav Wahlberg, Helena Liljenberg, Josef Groow (M&A), Alice Göransson (Employment Law), Avid Axelryd (Intellectual Property), Calle Tengwall Pagels, August Ahlin, Sara Jansson (Banking and Finance), Carla Håkansson, Katja Hägglund (Commercial Agreements), Frida Lansfjord, Jacob Guve, Alma Rotsman, Augus Olding (Assistants).

Read the client's press release here.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025